Clarification on China agencies’ redundancy reduction effort
This article was originally published in The Gray Sheet
Executive SummaryPlan for China's Administration of Quality Supervision, Inspection and Quarantine and its State Food and Drug Administration to reduce redundancies between them by requiring only one test, one report, one fee and one factory inspection, applies to eight specific device types (1"The Gray Sheet" Sept. 22, 2008, p. 8). Other device types were not affected by the problem. The eight types include: X-ray systems, hemodialysis systems, extracorporeal circulation tubes for blood purification, hollow-fiber dialyzers, heart-lung machines, electrocardiographs, pacemakers and condoms
You may also be interested in...
Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.
The new US-Mexico-Canada (USMCA) trade agreement includes language on enhancing regulatory compatibility between the three countries by recognizing quality systems audits performed under the Medical Device Single Audit Program (MDSAP). It also stipulates that each trading partner “consider its resources and technical capacity” in ensuring the safety, effectiveness and quality of devices – and more. Medtech industry advocacy group AdvaMed is praising the deal, reached by the three countries on 10 December.